413 related articles for article (PubMed ID: 12019078)
1. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Perea S; López-Ribot JL; Wickes BL; Kirkpatrick WR; Dib OP; Bachmann SP; Keller SM; Martinez M; Patterson TF
Antimicrob Agents Chemother; 2002 Jun; 46(6):1695-703. PubMed ID: 12019078
[TBL] [Abstract][Full Text] [Related]
2. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
[TBL] [Abstract][Full Text] [Related]
3. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.
Moran GP; Sullivan DJ; Henman MC; McCreary CE; Harrington BJ; Shanley DB; Coleman DC
Antimicrob Agents Chemother; 1997 Mar; 41(3):617-23. PubMed ID: 9056003
[TBL] [Abstract][Full Text] [Related]
4. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.
Moran GP; Sanglard D; Donnelly SM; Shanley DB; Sullivan DJ; Coleman DC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1819-30. PubMed ID: 9661028
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Lopez-Ribot JL; McAtee RK; Lee LN; Kirkpatrick WR; White TC; Sanglard D; Patterson TF
Antimicrob Agents Chemother; 1998 Nov; 42(11):2932-7. PubMed ID: 9797228
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
Perea S; López-Ribot JL; Kirkpatrick WR; McAtee RK; Santillán RA; Martínez M; Calabrese D; Sanglard D; Patterson TF
Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
[TBL] [Abstract][Full Text] [Related]
8. Resistance mechanisms in clinical isolates of Candida albicans.
White TC; Holleman S; Dy F; Mirels LF; Stevens DA
Antimicrob Agents Chemother; 2002 Jun; 46(6):1704-13. PubMed ID: 12019079
[TBL] [Abstract][Full Text] [Related]
9. Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.
Pinjon E; Jackson CJ; Kelly SL; Sanglard D; Moran G; Coleman DC; Sullivan DJ
Antimicrob Agents Chemother; 2005 Apr; 49(4):1312-8. PubMed ID: 15793103
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
[TBL] [Abstract][Full Text] [Related]
11. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Kirkpatrick WR; Revankar SG; Mcatee RK; Lopez-Ribot JL; Fothergill AW; McCarthy DI; Sanche SE; Cantu RA; Rinaldi MG; Patterson TF
J Clin Microbiol; 1998 Oct; 36(10):3007-12. PubMed ID: 9738058
[TBL] [Abstract][Full Text] [Related]
12. [Azole resistance in Candida albicans].
Perea S
Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
[TBL] [Abstract][Full Text] [Related]
13. Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
Lopez-Ribot JL; McAtee RK; Perea S; Kirkpatrick WR; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 1999 Jul; 43(7):1621-30. PubMed ID: 10390213
[TBL] [Abstract][Full Text] [Related]
14. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance genes and trailing growth in Candida albicans isolates.
Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of the overexpression of the ERG-11, MDR-1, CDR-1, and CDR-2 genes in fluconazole-resistant Candida albicans isolated from Ahvazian cancer patients with oral candidiasis.
Maheronnaghsh M; Teimoori A; Dehghan P; Fatahinia M
J Clin Lab Anal; 2022 Feb; 36(2):e24208. PubMed ID: 34997991
[TBL] [Abstract][Full Text] [Related]
18. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CDR1 and MDR1 Gene Expression and ERG11 Substitutions in Clinical Candida tropicalis Isolates from Alexandria, Egypt.
El-Kholy MA; Helaly GF; El Ghazzawi EF; El-Sawaf G; Shawky SM
Braz J Microbiol; 2023 Dec; 54(4):2609-2615. PubMed ID: 37606863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
